Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Abdel G. Babiker"'
Autor:
Matteo Quartagno, A. Sarah Walker, Abdel G. Babiker, Rebecca M. Turner, Mahesh K. B. Parmar, Andrew Copas, Ian R. White
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background Non-inferiority trials are increasingly used to evaluate new treatments that are expected to have secondary advantages over standard of care, but similar efficacy on the primary outcome. When designing a non-inferiority trial with
Externí odkaz:
https://doaj.org/article/bc0032c6c8f541488c8bbd694f8e5134
Autor:
Elizabeth C. George, Sarah Kiguli, Peter Olupot Olupot, Robert O. Opoka, Charles Engoru, Samuel O. Akech, Richard Nyeko, George Mtove, Ayub Mpoya, Margaret J. Thomason, Jane Crawley, Jennifer A. Evans, Diana M. Gibb, Abdel G. Babiker, Kathryn Maitland, A. Sarah Walker
Publikováno v:
Critical Care, Vol 23, Iss 1, Pp 1-9 (2019)
Abstract Background African children hospitalised with severe febrile illness have a high risk of mortality. The Fluid Expansion As Supportive Therapy (FEAST) trial (ISCRTN 69856593) demonstrated increased mortality risk associated with fluid boluses
Externí odkaz:
https://doaj.org/article/4a1e36db224240a68a1c152efaca72ad
Autor:
A. Aramburo, Jim Todd, Elizabeth C. George, Sarah Kiguli, Peter Olupot-Olupot, Robert O. Opoka, Charles Engoru, Samuel O. Akech, Richard Nyeko, George Mtove, Diana M. Gibb, Abdel G. Babiker, Kathryn Maitland
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background Hyperlactataemia (HL) is a biomarker of disease severity that predicts mortality in patients with sepsis and malaria. Lactate clearance (LC) during resuscitation has been shown to be a prognostic factor of survival in critically i
Externí odkaz:
https://doaj.org/article/4f40f6245e104f02a8f706ce4315e605
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-21 (2016)
Abstract Background There has been some debate in the literature as to whether baseline values of a measurement of interest at treatment initiation should be treated as an outcome variable as part of a model for longitudinal change or instead used as
Externí odkaz:
https://doaj.org/article/eff9b0cfa0ab4adf8d6c4182bb48c3ef
Autor:
Joanna Lewis, Helen Payne, A. Sarah Walker, Kennedy Otwombe, Diana M. Gibb, Abdel G. Babiker, Ravindre Panchia, Mark F. Cotton, Avy Violari, Nigel Klein, Robin E. Callard
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
ObjectivesEarly treatment of HIV-infected children and adults is important for optimal immune reconstitution. Infants’ immune systems are more plastic and dynamic than older children’s or adults’, and deserve particular attention. This study ai
Externí odkaz:
https://doaj.org/article/074ac667c7934ca09ddb917681c8b5b7
Autor:
Ella Marley-Zagar, Ian R. White, Patrick Royston, Friederike M.-S. Barthel, Mahesh K. B. Parmar, Abdel G. Babiker
Publikováno v:
The Stata Journal: Promoting communications on statistics and Stata. 23:24-52
We describe the command artbin, which offers various new facilities for the calculation of sample size for binary outcome variables that are not otherwise available in Stata. While artbin has been available since 2004, it has not been previously desc
Autor:
Cavan S Reilly, Álvaro H Borges, Jason V Baker, Sandra E Safo, Shweta Sharma, Mark N Polizzotto, James S Pankow, Xiaojun Hu, Brad T Sherman, Abdel G Babiker, Jens D Lundgren, H Clifford Lane
Publikováno v:
The Journal of Infectious Diseases. 227:951-960
Background There is an incompletely understood increased risk for cardiovascular disease (CVD) among people with HIV (PWH). We investigated if a collection of biomarkers were associated with CVD among PWH. Mendelian randomization (MR) was used to ide
Autor:
Ian R. White, Ella Marley-Zagar, Tim P. Morris, Mahesh K. B. Parmar, Patrick Royston, Abdel G. Babiker
Publikováno v:
Stata J
We describe a new command, artcat, that calculates sample size or power for a randomized controlled trial or similar experiment with an ordered categorical outcome, where analysis is by the proportional-odds model. artcat implements the method of Whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c420e6e67920857687e2c9fe51f4697c
https://europepmc.org/articles/PMC7614472/
https://europepmc.org/articles/PMC7614472/
Autor:
Abdel G Babiker, Jens Lundgren, Shweta Sharma, Birgit Grund, Andrew Phillips, Virginia L Kan, Gail Matthews, Karin L Klingman, James D Neaton
Publikováno v:
Open Forum Infectious Diseases. 9
Background Deferral of antiretroviral therapy (ART) initiation until CD4 count < 350 cells/μL in people with CD4 > 500 increases risk of AIDS and serious non-AIDS (SNA) conditions. Evidence from randomized trials is lacking to assess the extent to w
Autor:
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen MD, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane
Publikováno v:
Lancet (London, England)
Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific therapy for an outbreak infection such as SARS-CoV-2. Findings from randomi